Skip to main content
Log in

Cancer immunotherapy

Making allies of phagocytes

  • News & Views
  • Published:

From Nature Nanotechnology

View current issue Submit your manuscript

A versatile nanovaccine platform is based on a synthetic nanoparticle that not only acts as an antigen carrier but also stimulates the STING pathway.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Figure 1: Schematic illustration of the minimalist design of the PC7A nanovaccine.

References

  1. Luo, M. et al. Nat. Nanotech. 12, 648–654 (2017).

    Article  CAS  Google Scholar 

  2. Siddiqui, M. et al. BioDrugs 5, 313–316 (2006).

    Article  Google Scholar 

  3. Cubillos-Ruiz, J. R. et al. J. Clin. Invest. 119, 2231–2244 (2009).

    CAS  Google Scholar 

  4. Lizotte, P. H. et al. Nat. Nanotech. 11, 295–303 (2016).

    Article  CAS  Google Scholar 

  5. Ishikawa, H. et al. Nature 455, 674–678 (2008).

    Article  CAS  Google Scholar 

  6. Corrales, L. et al. J. Clin. Invest. 126, 2404–2411 (2016).

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Steven Fiering.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Fiering, S. Making allies of phagocytes. Nature Nanotech 12, 615–616 (2017). https://doi.org/10.1038/nnano.2017.89

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nnano.2017.89

  • Springer Nature Limited

This article is cited by

Navigation